Condition: Heart Failure · Cognitive Impairment · Sponsor: University of Alberta
CONVERGE-HF is a 4-center pilot phase IIb randomized control trial in ambulatory patients with chronic heart failure (≥ 6 months) and mild-to-moderate cognitive impairment.
This description comes directly from the study's public registry record.
Justin Ezekowitz, MBBCh, MSc · 780-492-0712 · jae2@ualberta.ca
Amanda Perreault, MSc · 780-492-5484 · aperreau@ualberta.ca
Always discuss trial participation with your own doctor first.
| University of Calgary | Calgary, Alberta, Canada | Recruiting |
| University of Alberta | Edmonton, Alberta, Canada | Recruiting |
| University of Ottawa | Ottawa, Ontario, Canada | Recruiting |
| McGill University Health Center | Montreal, Quebec, Canada | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06601465